NDC 68727-200-02 - Antizol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68727-200
- Requested NDC
- 68727-200-02
- Package NDCs from labels
- 68727-200-02, 68727-200-01
- Effective date
- 2007-02-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ANTIZOL ® (fomepizole) Injection | 2007-02-08 | Human prescription drug label | |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68727-200-01 | Antizol | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 | |
| 68727-200-02 | Antizol | 4 in 1 CARTON | INJECTION, SOLUTION | 4 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68727-200-02 | ML - Milliliter | 68727-200 | 99d43002-b872-42d8-8089-e2b7b01e9777 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| fomepizole | ACTIVE INGREDIENT | 83LCM6L2BY | ANTIZOL (FOMEPIZOLE) INJECTION, SOLUTION | 1 | |
| FOMEPIZOLE | ACTIVE MOIETY | 83LCM6L2BY | ANTIZOL (FOMEPIZOLE) INJECTION, SOLUTION | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fomepizole | FOMEPIZOLE | Zydus Pharmaceuticals USA Inc. | 256910fe-91f2-48f6-b0b4-55edc52dacd4 | 2025-11-20 | Adverse reactions | 310414 |
| Fomepizole | FOMEPIZOLE | Navinta LLC | 6fed6052-f159-46d6-8be1-31e18a7ba918 | 2024-12-19 | Adverse reactions | 310414 |
| Fomepizole | FOMEPIZOLE | Sagent Pharmaceuticals | 1dea37fd-ec17-416e-b28e-980a87d49e1a | 2023-10-26 | Adverse reactions | 310414 |
| Fomepizole | FOMEPIZOLE | Gland Pharma Limited | 7e133194-dacb-446a-a657-2d2430a02373 | 2023-07-07 | Adverse reactions | 310414 |
| Fomepizole | FOMEPIZOLE | Mylan Institutional LLC | 911312e2-3a7c-4c97-88a8-b8d92cd12923 | 2021-04-15 | Adverse reactions | 310414 |
| fomepizole | FOMEPIZOLE | American Regent, Inc. | a31d0148-2729-49de-b666-f24b0dfd2401 | 2020-02-11 | Adverse reactions | 310414 |
| fomepizole | FOMEPIZOLE | American Regent, Inc. | 82dc2920-af7f-4e43-9f6d-8877a71884cd | 2019-12-06 | Adverse reactions | 310414 |
| 7C6CA6E4-BE08-4BEA-8553-6B3374991A9E | 7C6CA6E4-BE08-4BEA-8553-6B3374991A9E | 2007-02-08 | Boxed warning, Adverse reactions | 7C6CA6E4-BE08-4BEA-8553-6B3374991A9E 7C6CA6E4-BE08-4BEA-8553-6B3374991A9E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.